Eli Lilly and Co. LLY enjoyed meteoric success with its weight loss drugs Mounjaro and Zepbound — the latter already…
In a move to demystify the conversation around obesity and weight management medications, Oprah Winfrey has taken to the airwaves…
Eli Lilly And Co’s LLY much-in-demand weight-loss drug Zepbound (tirzepatide) surged ahead with 77,590 new prescriptions in the U.S. for the…
The recent expansion of Novo Nordisk A/S’s NVO Wegovy’s (semaglutide) FDA approval has sparked a debate over insurance coverage for the drug. However,…
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments…
As the weight-loss frenzy fueled by social media endorsements and Hollywood glamour continues to surge, the battle against counterfeit medications has…
In response to growing reports of patient harm caused by counterfeit versions of its popular diabetes drug, Ozempic (semaglutide), Novo Nordisk…
Loading… Loading… NEW YORK, March 7, 2024 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for ORCL, CAH, HPE, NVO, and…
© Reuters. Boxes of Wegovy lie beside a packaging line at Novo Nordisk’s facility in Hillerod, Denmark, March 8, 2024….
Novo Nordisk A/S NVO’s Wegovy garnered the Food and Drug Administration’s approval for expanded use Friday, marking what the drugmaker…